
Senseonics Holdings (SENS) Stock Forecast & Price Target
Senseonics Holdings (SENS) Analyst Ratings
Bulls say
Senseonics Holdings Inc. is projected to experience a significant revenue increase, with total revenues expected to reach $75.6 million in 2026 and $118.4 million in 2027, reflecting a robust growth trajectory. The company has demonstrated strong performance, with a year-over-year topline revenue increase of 90% in the first half of the year, further supported by an improvement in gross margins, which reached 43% in Q3. A notable driver of this growth is the 160% year-over-year rise in new patients transitioning to the Eversense 365 system, underscoring the demand for its differentiated glucose monitoring technology.
Bears say
Senseonics Holdings Inc. is projected to experience relatively flat revenue growth in the first half of 2025, attributed to the ongoing transition from its previous U.S. product offering, indicating potential challenges in market adoption and product differentiation. Despite reporting total revenues of $8.1 million for the quarter, exceeding consensus estimates, the company recorded a net loss of $0.43 per share, which is higher than the expected loss of $0.40 per share, highlighting ongoing financial pressures. The reliance on international markets for the majority of its revenue, coupled with persistent losses, raises concerns about the company's ability to sustain growth and address the unmet demand for its long-term glucose monitoring solutions.
This aggregate rating is based on analysts' research of Senseonics Holdings and is not a guaranteed prediction by Public.com or investment advice.
Senseonics Holdings (SENS) Analyst Forecast & Price Prediction
Start investing in Senseonics Holdings (SENS)
Order type
Buy in
Order amount
Est. shares
0 shares